Harvard Mental Health Letter

References for “Medications for Alzheimer’s disease”

Atri A, et al. "Long-Term Course and Effectiveness of Combination Therapy in Alzheimer's Disease," Alzheimer's Disease & Associated Disorders (July/Sept. 2008): Vol. 22, No. 3, pp. 209–21. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed/18580597

Ballard C, et al. "The Dementia Antipsychotic Withdrawal Trial (DART-AD): Long-Term Follow-Up of a Randomised Placebo-Controlled Trial," Lancet Neurology (Feb. 2009): Vol. 8, No. 2, pp. 151–57. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed/19138567

Birks J. "Cholinesterase Inhibitors for Alzheimer's Disease," Cochrane Database of Systematic Reviews (Jan. 25, 2006): Doc. No. CD005593. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed/16437532

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »